Conor Ramps Up Production Of CoStar Stent To Prep For U.S. Launch

Conor Medsystems is already boosting manufacturing capacity in preparation for the U.S. launch of its CoStar drug-eluting stent, though the product is not slated to hit the market until late next year at the earliest

More from Archive

More from Medtech Insight